Axial - agency for great inventors
Investment Stage: Series A
Portfolio 56
| Date | Name | Website | Total Raised | Location |
| 16.09.2024 | Euler Biol... | euler.bio | - | - |
| 16.09.2024 | Insamo | insamo.com | $12M | - |
| 16.09.2024 | SynsoryBio | synsorybio.com | - | - |
| 16.09.2024 | Lyell Immu... | lyell.com | - | United Sta... |
| 16.09.2024 | Papa | papa.com | - | United Sta... |
| 28.02.2023 | Nalu Bio | nalubio.com | $12M | United Sta... |
| - | Minded | tryminded.com | $25M | - |
| - | Concerto B... | concertobio.com | $47.54M | United Sta... |
| - | Nexilico | nexilico.com | - | United Sta... |
| - | CHARM Ther... | charmtx.com | $50M | United Kin... |
Show more
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Joshua | Elkington | - | linkedin.c... | - | i**o@axial... |
Mentions in press and media 3
| Date | Title | Description |
| 10.06.2022 | London’s Charm Therapeutics raises $50 million as it takes on cancer treatment | Charm Therapeutics has raised $50 million in a Series A funding round co-led by F-Prime Capital and OrbiMed. The capital is slated to be used to further the company’s ambitions of transforming structure-based drug discovery, namely via its ... |
| 16.02.2022 | Rubi Laboratories raises $4.5m in seed funding to supply major fashion brands with carbon-negative textiles | "We're at a pivotal moment in time where mature modern technologies and advances in biotech can meet to build a world where human prosperity and economic growth are planet-positive." SAN FRANCISCO (PRWEB) February 16, 2022 Today, ... |
| - | London’s Charm Therapeutics raises $50 million as it takes on cancer treatment | Charm Therapeutics has raised $50 million in a Series A funding round co-led by F-Prime Capital and OrbiMed. The capital is slated to be used to further the company’s ambitions of transforming structure-based drug discovery, namely via its ... |